Bristol Myers Squibb Ipilimumab Patient Information Guide

This document is about Ipilimumab, an immunotherapy drug used to treat advanced melanoma.


Bristol Myers Squibb Ipilimumab Patient Information Guide - cover page
Brand
Bristol-Myers Squibb
Category
Drugs
Document type
User Manual
Language
Spanish
Pages
9
File format
PDF
File size
491 KB
Published
16 November, 2023
Updated
16 November, 2023
MD5 checksum
5B49196692C659FC908550CB1F43CC18

About this manual

This Spanish-language patient guide for Ipilimumab explains what the treatment is, how the medicine works with the immune system, and which signs and symptoms may appear during or after treatment. It describes the checks the doctor performs before starting treatment and lists possible side effects by body area, including intestinal and stomach, eye, liver, nervous system, skin and general effects.

The guide also covers other important adverse events such as complications after an allogeneic stem cell transplant and infusion reactions, and it includes a Patient Alert Card that the patient should carry at all times, with space for the prescribing doctor's contact details. Free telephone numbers for BMS Medical Information in several Latin American countries are listed. This manual is written in Spanish.

What's inside

  • Introduction
  • About Ipilimumab
  • What to check with your doctor before starting treatment
  • Main adverse events of your treatment
  • Possible intestinal and stomach, eye, liver, nervous system, skin and general adverse events
  • Other important adverse events (stem cell transplant complications, infusion reactions)
  • Patient Alert Card
  • My doctor's contact information

Specifications

Active substanceA protein that helps the immune system attack and destroy cancer cells
Timing of infusion reactionsUsually during or within 24 hours of receiving the dose

Frequently asked questions

What is in Ipilimumab and how does it work?

Ipilimumab contains a protein as its active substance, which helps the immune system's T lymphocytes fight cancer cells.

When can the signs and symptoms of adverse events appear?

They can occur at any time during treatment or even months after treatment has ended.

What should I do if I suspect an adverse event?

Call your doctor immediately if you have any sign or symptom, or if they persist or worsen, and do not treat them on your own.

What is the Patient Alert Card for?

It reminds you of symptoms you should report right away to your doctor or nurse and lets other doctors know you are being treated with Ipilimumab.

Download PDF (491 KB)

More Bristol-Myers Squibb Manuals


View all Bristol-Myers Squibb manuals →